News & Perspective

Apr 15, 2011

Apr 15, 2011

Resistant S aureus found in raw meat, poultry

(CIDRAP News) – Scientists report that they found the common pathogen Staphylococus aureus on close to half of 136 raw meat and poultry samples from five US cities and that more than half of the isolates were resistant to several antibiotics, but they say the public health significance of the findings is not clear.

Apr 07, 2011

Apr 07, 2011

IDSA calls for broad attack on antimicrobial resistance

(CIDRAP News) – Warning that medical procedures such as surgery and chemotherapy will become impossible if current trends continue, the Infectious Diseases Society of America (IDSA) today called for a many-pronged campaign to counter the ever-growing threat of antimicrobial resistance.

Mar 17, 2011

Mar 17, 2011

Vaccinia infections shared link to martial arts gym

(CIDRAP News) – The US Centers for Disease Control and Prevention (CDC) yesterday reported on a cluster of four cases of vaccinia virus infection in 2008 that were linked to a martial arts gym in Maryland.

The investigation included lab and public health officials from Michigan and Maryland and was detailed in the CDC's Emerging Infectious Diseases (EID) journal.

Jan 05, 2011

Jan 05, 2011

IDSA issues guidelines for treating MRSA infections

(CIDRAP News) – Saying current treatment practices vary widely, the Infectious Diseases Society of America (IDSA) today released lengthy guidelines for treating methicillin-resistant Staphylococcus aureus (MRSA) infections, which the group said now account for most of the skin infections that send people to emergency rooms.

Nov 04, 2010

Nov 04, 2010

Grants for small biotechs include infectious-disease projects

(CIDRAP News) – Federal officials announced yesterday that $1 billion worth of grants and tax credits will be awarded to thousands of small biotechnology companies to support the development of new medical therapies, including a number of products for infectious diseases.

Aug 30, 2010

Aug 30, 2010

HHS funds development of drug for plague, tularemia

(CIDRAP News) – The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.

Pages

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get news & practices.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M United Health Foundation Gilead Become an underwriter»